ISO/TS 16766:2024

Manufacturers’ considerations for in vitro diagnostic medical devices in a public health emergency ISO/TS 16766:2024

Publication date:   Nov 19, 2024

General information

60.60 Standard published   Nov 19, 2024

ISO

ISO/TC 212 Clinical laboratory testing and in vitro diagnostic test systems

Technical Specification

11.100.10   In vitro diagnostic test systems

Buying

Published

Language in which you want to receive the document.

Scope

This document provides guidance to manufacturers on the minimum requirements for the lifecycle management of in vitro diagnostic (IVD) medical devices that are developed in preparation for and in response to a public health emergency involving infectious agents requiring immediate availability of authorized IVD devices.
NOTE            This document does not replace existing national (or regional) regulatory pathway requirements for IVD medical devices under non-emergency situations. The regulatory authorization process of emergency use-IVD medical devices is country-specific and it includes:
—                   following a risk management process;
—                   monitoring the device’s post-market performance and quality assurance;
—                   implementing a communication system.

Life cycle

NOW

PUBLISHED
ISO/TS 16766:2024
60.60 Standard published
Nov 19, 2024